Quick Takeaways
- This page summarizes Sean Werner's Form 4 filing for BIOLIFE SOLUTIONS INC (BLFS).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 22 Jul 2025, 17:33.
Sean Werner - 18 Jul 2025 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)
- Signature
- /s/ Sean Werner
- Issuer symbol
- BLFS
- Transactions as of
- 18 Jul 2025
- Net transactions value
- -$23,660
- Form type
- 4
- Filing time
- 22 Jul 2025, 17:33:30 UTC
- Previous filing
- 12 Jun 2025
- Next filing
- 28 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Sean Werner filed Form 4 for BIOLIFE SOLUTIONS INC (BLFS) on 22 Jul 2025."
What Changed
- Previous filing in this sequence was filed on 12 Jun 2025.
- Current net transaction value: -$23,660.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Werner Sean | Chief Technology Officer | 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL | /s/ Sean Werner | 22 Jul 2025 | 0002047541 |
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BLFS | Common Stock | Sale | $23,660 | -1,115 | -4% | $21.22 | 26,495 | 18 Jul 2025 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 07-17-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. |